142 / 160
694
REFERENCIAS BIBLIOGRáFICAS
1. Aslam S, Musher DM. An update of diagnosis, treatment and
prevention of Clostridium difficile. Gastroenterol Clin N Am
2006; 35: 315-35.
2. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice
guidelines for Clostridium difficile infection in adults: 2010
update by the Society for healthcare epidemiology of America
(SHEA) and the Infectious diseases society of America (IDSA).
Infect Control Hosp Epidemiol 2010; 31:431- 455.
3. Carvajal S. Diarrea asociada a antibióticos. Diagnóstico
y tratamiento de las enfermedades digestivas. Soc. Chi.
Gastroenterol. 2013; 217-22.
4. Hall IC, O’Toole E. Intestinal flora in newborn infants with a
description of a new pathogenic anaerobe, Bacillus difficilis.
Am J Dis Child 1935; 49:390-3.
5. Zilberberg MD, Shorr AF, Kollef MH. Increase in Adult
Clostridium Difficile related Hospitalizations and Case-Fatality
Rate, United States, 2000–2005. Emerg Infect Dis. 2008 Jun;
14 (6) 929-31.
6. Chitnis AS, Holzbauer SM, Belflower RM, et al. Epidemiology
of communityassociated Clostridium difficile infection, 2009
through 2011. JAMA Intern Med 2013; 173: 1359-67.
7. Leffler D, Lamont J.T, .Clostridium difficile Infection N Engl J
Med 2015; 372:1539-1548 April 16, 2015DOI: 10.1056/NEJ
Mra1403772
8. Pérez M, Hurtado AI, Couto I, et al. Abordaje multidisciplinario
de la infección por Clostridium difficile. Rev Chilena Infectol
2013; 30 (2): 165-185.
9. Poutanen SM, Simor AE. Clostridium Difficile-associated
diarrhea in adults. CMAJ. 2004 July 6; 171(1): 51-58.
10. Voth DE, Ballard JD. Action and Role in Disease Clostridium
Difficile Toxins: Mechanism of Action and Role in Disease. Clin
Microbiol. Rev. 2005, 18(2): 247-63.
11. Bartlett JG, Chang TW, Gurwith M, et al. Antibiotic-associated
pseudomembranous colitis due to toxin-producing clostridia.
New Engl J Med. 1978; 298: 531-534.
12. Diggs NG, Surawicz CM. Evolving Concepts in Clostridium
Difficile Colitis. Curr Gastroenterol Rep 2009; 11: 400-405.
13. Sethi AK, Al –Nassir WN, Nerandzic MM, Bobulsky GS, Donskey
CJ. Persistence of skin contamination environmental shedding
of Clostridium difficile during and after treatment of C.difficile
infection.Infect Control Hosp Epidemiol 2010;31:21-7.
14. Tenover FC, Baron EJ, Peterson LR, Persing DH. Laboratory
Diagnosis of Clostridium Difficile Infection. Can Molecular
Amplification Methods Move Us Out of Uncertainty? J Mol
Diagn 2011; 13: 573-582.
15. O’Horo JC, Jones A, Sternke M, Harper C, Safdar N. Molecular
Techniques for Diagnosis of Clostridium Difficile Infection:
Systematic Review and Metaanalysis. Mayo Clin Proc. 2012;
87 (7): 643-651.
16. Hernández-Rocha C, Naour S, Alvarez-Lobos M y col. Infecciones
causadas por Clostridium Difficile: una visión actualizada. Rev
Chilena Infectol 2012; 29: 434-445.
17. Zar FA, Bakkanagari SR, Moorthi KM et al. A comparison
of vancomycin and metronidazole for the treatment of
Clostridium Difficile – associated diarrhea, stratified by disease
severity. Clin Infect Dis 2007; 45: 302-7.
18. Lamontagne F, Labbé AC, Haeck O, Lesur O, Lalancette M,Patino
C, et al.Impact of emergency colectomy on survival of patients
with fulminat Clostridium difficile colitis during an epidemic
caused by a hypervirulent strain.Ann Surg 2007;245 (2):
267-72.
19. Neal MD, Alverdy JC,Hall DE, Simmons RL, Zuckerbraun BS.
Diverting loop ileostomy and colonic lavage: an alternative
to total abdominal colectomy for the treatment of
severe,complicated Clostridium difficile associated disease .
Ann Surg 2011;254:423-7.
20. Brandt L J, Aroniadis O C. An overview of fecal microbiota
transplantation: techniques, indications, and outcomes.
Gastrointest Endosc 2013; 78: 240-9.
21. Cornely OA, Crook DW, Esposito R,et al. Fidaxomicin versus
vancomycin for infection with Clostridium Difficile in Europe,
Canada, and the USA: a double-blind, non-inferiority,
randomised controlled trial. Lancet Infect Dis 2012; 12:
281-89.
22. Eiseman B, Silen W, Bascom G S, Kauvar A J. Fecal enema as an
adjunct in the treatment of pseudomembranous enterocolitis.
Surgery 1958; 44: 854-9.
23. Issa I, Moucari R.Probiotics for antibiotic-associated diarrea:
Do we have a veredict? World J Gastroenterol. 2014 Dec 21;
20(47): 17788-95.
El autor declara no tener conflictos de interés, en relación a este artículo.
adecuado y racional de antibióticos, diagnóstico oportuno y
precoz, educación al paciente y familiares respecto al mecanismo
de contagio, implementar medidas de control de la infección
disponiendo de la infraestructura que esto requiera, como por
ejemplo contar en los centros de salud con: áreas de lavado de
manos, normas de precaución de contacto, habitaciones privadas,
limpieza y desinfección ambiental. Para lo anterior, es fundamental
el trabajo en equipo, involucrando a todo el personal de salud,
sugiriéndose que cada centro u hospital, cuente con un sistema
de control de infecciones asociadas a la atención de salud (IAAS),
siendo esto parte de la gestión de calidad y seguridad de la aten-
ción de los pacientes. También el desarrollo futuro de vacunas (no
disponible en la actualidad), será de gran utilidad.
[REV. MED. CLIN. CONDES - 2015; 26(5) 687-695]